Youll want to ensure their programs align with your PBMs formulary, and that they have a process for finding lower-cost alternatives and supporting medication de-escalation
They are simple adhesive matrices without the pharmaceutical engineering that makes nicotine patches work
Foundayo: side effect differences Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron) are all GLP-1 receptor agonists, but they are not identical
The lack of statistically significant effect on this outcome, which was repeatedly demonstrated to improve in the CVOTs with GLP-1 RAs [12], can be explained by the irregularity of UACR sampling in real-world setting compared with CVOTs
Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
Specifically, retatrutide simultaneously activates three incretin and metabolic hormone receptors: GLP-1 (glucagon-like peptide-1) receptor which reduces appetite and slows gastric emptying [6] [7] GIP (glucose-dependent insulinotropic polypeptide) receptor which enhances insulin secretion and may improve fat metabolism [9] [10] Glucagon receptor which may increase energy expenditure and, based on early clinical and preclinical data, could promote hepatic fat metabolism This triple-action mechanism sets retatrutide apart from existing approved therapies such as semaglutide (a GLP-1 agonist) or tirzepatide (a dual GLP-1/GIP agonist)
